Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. Learn More.
Learn More. Edit Content. 03. Investors. Learn More. ORMP. $2.29. Oramed Pharmaceuticals Inc. 1.82%. Volume$98.73K. Market cap$90.76M. Corporate presentation.
Find annual and quearterly earnings data for Oramed Pharmaceuticals Inc. Common Stock (ORMP) including earnings per share, earnings forecasts at Nasdaq.com.
People also ask
Is ORMP a good stock to buy?
What is the future of ORMP?
Why is ORMP stock dropping?
What is the announcement of Oramed?
Latest Filings (excluding insider transactions) ; March 22, 2024 - SC 13D: General statement of acquisition of beneficial ownershipOpen document ; FilingOpen ...
Find the latest Oramed Pharmaceuticals Inc. Common Stock (ORMP) annual income statements, balance sheets, financial statements, ratios, and cash flow data ...
Get the latest Oramed Pharmaceuticals Inc. (ORMP) stock news and headlines to help you in your trading and investing decisions.
Missing: relations | Show results with:relations
Oramed Pharmaceuticals Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ORMP financial statements in full.
Missing: relations | Show results with:relations
Oramed Pharmaceuticals (ORMP) will release its next earnings report on Jul 10, 2024 ... investors and does not represent returns that any investor actually ...
Missing: relations | Show results with:relations
Oramed Pharmaceuticals Inc. is currently listed on NASDAQ under ORMP. One share of ORMP stock can currently be purchased for approximately $2.52. Is Oramed ...
Missing: relations | Show results with:relations
General Technical Agreement between Oramed Ltd. and Premas Biotech Pvt. Ltd., dated July 24, 2016 (Confidential treatment has been granted for portions of this ...